Cargando…
Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis
The prevalence of nonalcoholic fatty liver disease (NAFLD) is rapidly growing throughout the world. Nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD, is likely to become the leading cause of cirrhosis and etiology for liver transplantation in future decades in the Western World. Mo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hellenic Society of Gastroenterology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062842/ https://www.ncbi.nlm.nih.gov/pubmed/35599922 http://dx.doi.org/10.20524/aog.2022.0704 |